搜索结果: 31-45 共查到“医学 hepatitis C”相关记录89条 . 查询时间(0.046 秒)
Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
Hepatitis B virus hepatitis C virus coinfection epidemiology hepatocellular carcinoma
2011/4/2
Approximately 350 million people are infected with HBV worldwide, and the World Health Organization (WHO) estimates that approximately 170 million people are infected with HCV. HBV and HCV infection a...
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients
chronic hepatitis coinfection HBV HCV histology
2011/4/2
Background:
The aim of the present study was to compare the histological characteristics of livers between chronic hepatitis C (CHC) patients with and without hepatitis B virus (HBV) coinfection.
Me...
Hepatitis B virus and hepatitis C virus co-infection:additive players in chronic liver disease?
Hepatitis B virus Hepatitis V virus genotypes Hepatitis C virus Hepadnavirus Interferon
2011/4/2
Hepatitis B virus (HBV) and hepatitis C virus (HCV) share modes of transmission and their combined infection is a fairly frequent occurrence particularly in areas where the two viruses are endemic and...
Understanding the Pathogenesis and Management of Hepatitis B/HIV and Hepatitis B/Hepatitis C Virus and Hepatitis B/Hepatitis C Virus
B/Hepatitis C Virus Management
2011/4/2
Hepatitis B virus (HBV) pathogenesis is influenced by a variety of factors
including coinfection with other viruses, most notably HIV and hepatitis C
virus (HCV). Dual virus infection can modify the...
Clevudine myopathy in patients with chronic hepatitis B
Clevudine Hepatitis B Adverse effects Myopathy
2011/4/2
Clevudine (L-FMAU) is a thymidine L-nucleoside analogue that was recently introduced for the treatment of chronic
hepatitis B virus infection. Previous studies showed that clevudine has potent and su...
Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B
Clevudine Telbivudine Mitochondrial toxicity Pegylated interferon
2011/4/2
The development of clevudine as a treatment for hepatitis B was terminated recently because of case reports of myopathy.
In each case, the onset of symptoms occurred between 8 and 13 months after the...
Treatment of viral hepatitis in China: better clinical research and improved practice
viral hepatitis therapeutics China advance
2011/4/2
Hepatitis virus infection, especially chronic infection
with hepatitis B virus (HBV) and hepatitis C virus
(HCV), is a serious issue to global public health.
Although the prevalence of HBsAg in the...
Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients
Virological biochemical entecavir treatment
2011/4/2
Hepatitis B virus (HBV) infection has a high prevalence
in China. Entecavir has shown superior efficacy over
lamivudine in Chinese nucleoside-naive chronic hepatitis B
(CHB) patients over 48 weeks,...
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Monotherapy versus therapy the treatment of chronic hepatitis B
2011/4/2
Nucleos(t)ide analogues, active against hepatitis B polymerase, suppress viral replication and improve clinical outcome. However, the emergence of drug-resistant mutants can result in treatment failur...
Hepatitis B virus is estimated to have infected 350 million individuals globally, accounting for over 500 000 deaths each year.1 An effective and widely available vaccine provides protection from infe...
HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
HBeAg seroconversion in the treatment of chronic hepatitis B
2011/4/1
During the natural history of chronic hepatitis
B virus (HBV) infection, the loss of serum hepatitis B e
antigen (HBeAg) and the development of anti-HBe antibodies
(HBeAg seroconversion) mark a tra...
10,000 Hepatitis C patients could hold the key to better treatment
Medical Research Council Hepatitis C patients HCV
2011/2/25
The Medical Research Foundation, an independent registered charity established by the Medical Research Council (MRC), has donated nearly £2 million to establish a clinical database of 10,000 pat...
Hepatitis C Genotypes in Hemophilia Patients in Iran
Hepatitis C Genotypes Hemophilia Patients
2015/9/22
I genuinely enjoyed reading the excellent and informative original article by Keshvari and colleagues in your journal recently.1 Patients with hemophilia are at greater risk for all forms of viral hep...
The Efficacy of Hepatitis B Vaccination among School Age Children in Southern Iran
Hepatitis B Vaccination Efficacy Southern Iran
2015/9/22
Background: Primary prevention by vaccination to increase herd immunity remains the main thrust in the control of hepatitis B virus (HBV) infection and many countries such as Islamic Republic of Iran ...
Can Stereological Studies Be Helpful in Differentiating Biliary Atresia from Neonatal Hepatitis?
Cholestasis Biliary atresia Neonatal Hepaatitis Stereology Liver biopsy
2015/9/21
Cholestatic jaundice is a potentially dangerous condition which is often misdiagnosed by paediatricians as physiological or breast milk jaundice. The two most common causes of neonatal cholestasis (NC...